Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Exon 51 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/08/599   
Active ingredient: Exon 51 specific phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Glaxo Group Ltd
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Centralised Orphan - Designation EMEA/OD/082/08 (2009)1525 of 27/02/2009
08/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/082/08/T/01 (2010)3713 of 04/06/2010
04/02/2014 Centralised Orphan - Change of address